Literature DB >> 24531802

Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.

Adam Mohmand-Borkowski1, W H Wilson Tang.   

Abstract

While atrial fibrillation is common comorbidity in patients with cardiomyopathy and heart failure, diagnosis and management often focuses on tackling rate and rhythm control rather than elucidating pathogenic mechanisms related to underlying myocardial substrates. This review summarizes our current understanding of the natural history of cardiomyopathies presenting with atrial fibrillation, and the importance of managing underlying cardiomyopathic condition as diagnostic and treatment strategy for atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531802     DOI: 10.1007/s10741-014-9424-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  43 in total

1.  Atrial fibrillation substrate: the "unknown species"-- from lone atrial fibrillation to fibrotic atrial cardiomyopathy.

Authors:  Hans Kottkamp
Journal:  Heart Rhythm       Date:  2012-01-11       Impact factor: 6.343

2.  Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study.

Authors:  M A Tedesco; G Di Salvo; G Ratti; F Natale; D Iarussi; A Iacono
Journal:  Clin Cardiol       Date:  2001-09       Impact factor: 2.882

3.  Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.

Authors:  Paolo Di Donna; Iacopo Olivotto; Sara Dalila Luisella Delcrè; Domenico Caponi; Marco Scaglione; Isabelle Nault; Antonio Montefusco; Francesca Girolami; Franco Cecchi; Michel Haissaguerre; Fiorenzo Gaita
Journal:  Europace       Date:  2010-03       Impact factor: 5.214

4.  Reversal of left ventricular dysfunction following ablation of atrial fibrillation.

Authors:  Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-11-01

5.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

6.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

7.  Ventricular dysfunction: tachycardia induced cardiomyopathy.

Authors:  V Ramesh Iyer
Journal:  Indian Pacing Electrophysiol J       Date:  2008-05-01

8.  Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  T Jared Bunch; Thomas M Munger; Paul A Friedman; Samuel J Asirvatham; Peter A Brady; Yong-Mei Cha; Robert F Rea; Win-Kuang Shen; Brian D Powell; Steve R Ommen; Kristi H Monahan; Janis M Haroldson; Douglas L Packer
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-09

9.  Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy.

Authors:  Hiroshi Watanabe; Kazuki Okamura; Masaomi Chinushi; Hiroshi Furushima; Yasutaka Tanabe; Makoto Kodama; Yoshifusa Aizawa
Journal:  Int Heart J       Date:  2008-01       Impact factor: 1.862

10.  Natural history of Danon disease.

Authors:  Dana Boucek; Jean Jirikowic; Matthew Taylor
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.